Skip to Content

CFRA Lowers Globe Life Share Target, Reflecting Varied Growth Outlook

The adjusted target price reflects a valuation of 10.3 times the firm’s estimated 2024 operating earnings per share (EPS) of \(11.50 and 9.6 times the 2025 operating EPS estimate of \)12.25. This modification considers Globe Life’s performance and market position among its industry counterparts.

The rationale for the updated price target is based on the anticipation of Globe Life achieving a 4%-6% operating revenue growth in 2024 and a 3%-7% growth in 2025, slightly surpassing industry norms. In the preceding year, Globe Life observed a 3.6% increase in life insurance premiums, with expectations of a 4%-7% growth in the current year.

However, concerns have emerged regarding the potential impact of ongoing inflationary pressures on Globe Life’s middle-income customer base. This could lead to a decline in sales as consumers adjust their spending habits in response to heightened costs, including those related to auto insurance.

In 2023, the company witnessed a 2.8% rise in health insurance premiums, with a projected growth of 3%-5% in 2024. Nevertheless, this sector faces escalating competition that may influence the company’s performance. CFRA’s evaluation also considers Globe Life’s risk profile, which is deemed below that of its peers due to the straightforward nature of its insurance offerings.

After evaluating the risk profile and the stock’s premium valuation relative to industry competitors, CFRA concludes that Globe Life shares are fairly valued at the current price level.

In the context of CFRA’s updated assessment of Globe Life Inc. (NYSE: GL), real-time data from InvestingPro offers a comprehensive view of the company’s financial standing and market performance. With a market capitalization of around $9.87 billion and a P/E ratio of 10.15 in the last twelve months as of Q4 2023, Globe Life is trading at a relatively modest multiple, which could attract value investors. The company’s revenue growth of 4.22% during the same period aligns with CFRA’s forecasts, indicating a steady upward trajectory.

InvestingPro highlights two pertinent tips for investors: Globe Life has increased its dividend for 8 consecutive years, demonstrating a commitment to shareholder value, and the stock is trading close to its 52-week low, potentially presenting an appealing entry opportunity. Despite recent price declines, evidenced by a 1-month total return of -12.76%, the company’s fundamental strengths, including a 15.66% dividend growth in the past year, remain robust.

For a more thorough analysis of Globe Life’s investment prospects, additional InvestingPro Tips are available to aid in decision-making. To access a full array of insights, consider using the coupon code PRONEWS24 for an extra 10% discount on a yearly or biyearly Pro and Pro+ subscription at InvestingPro. Six supplementary tips on Globe Life are provided to offer a comprehensive outlook on the stock’s potential.